Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients

Preben Bo Mortensen
In: Acta Psychiatrica Scandinavica · 1987 · vol. 75(6) , pp. 585–590 · doi:10.1111/j.1600-0447.1987.tb02839.x · PMID:2887088 · W2052718636
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher

Abstract

In a Danish cohort of schizophrenics consisting of 6,168 patients followed during 1957-1980, the incidence of certain types of cancer has been shown to be significantly decreased (5). From this cohort 30 males with lung cancer, 21 males with bladder cancer, 17 females with cancer of the uterine cervix and 40 females with breast cancer, were each matched to two "healthy" schizophrenic controls from the same cohort. A range of social, demographic and nosocomial factors were registered from the individual case files, and statistical analysis was carried out, using Cox's regression model. Neuroleptic treatment with various drugs other than reserpine reduced the risk of developing all four cancer types studied. In contrast reserpine treatment increased the risk of developing cancer of the breast and uterine cervix. Furthermore, cancer risk was found to be modified by other well-known risk factors.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (32)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK